rs2241745
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Diabetes
0.010
GeneticVariation
BEFREE
Diabetes status modified the associations between rs4876369 and rs2241745 and BC incidence, on the multiplicative interaction scale.
30457165
2019
rs2241745
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Diabetes Mellitus
0.010
GeneticVariation
BEFREE
Diabetes status modified the associations between rs4876369 and rs2241745 and BC incidence, on the multiplicative interaction scale.
30457165
2019
rs2241745
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Malignant neoplasm of breast
0.010
GeneticVariation
BEFREE
Diabetes status modified the associations between rs4876369 and rs2241745 and BC incidence, on the multiplicative interaction scale.
30457165
2019
rs2241745
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Breast Carcinoma
0.010
GeneticVariation
BEFREE
Diabetes status modified the associations between rs4876369 and rs2241745 and BC incidence, on the multiplicative interaction scale.
30457165
2019
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Malignant neoplasm of colon and/or rectum
0.010
GeneticVariation
BEFREE
IRS-2 rs1805097 polymorphism is associated with the decreased risk of colorectal cancer .
28212577
2017
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Colorectal Carcinoma
0.010
GeneticVariation
BEFREE
Stratification analysis of ethnicity fo und that rs1805097 polymorp hism decreased the risk of C</span>RC among Americans.
28212577
2017
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Epilepsy, Temporal Lobe
0.010
GeneticVariation
BEFREE
IRS2 1057G/A combined with the INSR His 1085 His polymorphism increased the odds ratio of drug resistance in TLE (P=0.011, OR=2.263, 95% CI: 1.208-4.239).
25458098
2015
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Gestational Diabetes
0.010
GeneticVariation
BEFREE
The G1057D polymorphism of insulin receptor substrate-2 associated with gestational diabetes mellitus .
24401133
2014
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Malignant neoplasm of breast
0.010
GeneticVariation
BEFREE
This meta-analysis indicated that IRS2 rs1805097 polymorphism was not associated with colorectal and breast cancer risk.
24497996
2014
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Breast Carcinoma
0.010
GeneticVariation
BEFREE
This meta-analysis indicated that IRS2 rs1805097 polymorphism was not associated with colorectal and breast cancer risk.
24497996
2014
rs2289046
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Colorectal Carcinoma
0.010
GeneticVariation
BEFREE
However, the evidence for a link between the IRS2 (rs2289046 ) variant and risk of CRC dependent on the BMI of the subjects, requires confirmation in subsequent studies with greater sample size.
24175768
2013
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Diabetes Mellitus
0.010
GeneticVariation
BEFREE
The concurrence of Gly1057Asp polymorphism in IRS-2 with DM is correlated with occurrence of CAD.
23216712
2012
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Coronary heart disease
0.010
GeneticVariation
BEFREE
Gly1057Asp polymorphism of insulin receptor substrate-2 is associated with coronary artery disease in the Taiwanese population.
23216712
2012
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Coronary Arteriosclerosis
0.010
GeneticVariation
BEFREE
Gly1057Asp polymorphism of insulin receptor substrate-2 is associated with coronary artery disease in the Taiwanese population.
23216712
2012
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Coronary Artery Disease
0.010
GeneticVariation
BEFREE
The concurrence of Gly1057Asp polymorphism in IRS-2 with DM is correlated with occurrence of CAD .
23216712
2012
rs2289046
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Metabolic Syndrome X
0.010
GeneticVariation
BEFREE
The rs2289046 polymorphism at the IRS2 gene locus may influence insulin sensitivity by interacting with certain plasma fatty acids in MetS subjects.
22147666
2012
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Endometriosis
0.010
GeneticVariation
BEFREE
These results suggest that the IRS2 G1057D polymorphism may be associated with an increased risk for endometriosis .
19878940
2010
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Endometrial Carcinoma
0.010
GeneticVariation
BEFREE
These results suggest that IRS-2 G1057D polymorphism may be associated with endometrial cancer .
20184486
2010
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Malignant neoplasm of endometrium
0.010
GeneticVariation
BEFREE
These results suggest that IRS-2 G1057D polymorphism may be associated with endometrial cancer .
20184486
2010
rs2289046
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Asthma
0.010
GeneticVariation
BEFREE
In asthmatics , IRS2 (rs2289046 ) was associated with high total IgE levels.
19604268
2009
rs2289046
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Malignant neoplasm of breast
0.010
GeneticVariation
BEFREE
When these three SNPs were examined as a haplotype, only the hap lotype that included the G allele of rs2289046 was associated with breast cancer (odds ratio = 0.76, 95% confidence interval = 0.63-0.92 for TGC versus CAT).
18611262
2008
rs2289046
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Breast Carcinoma
0.010
GeneticVariation
BEFREE
When these three SNPs were examined as a haplotype, only the hap lotype that included the G allele of rs2289046 was associated with breast cancer (odds ratio = 0.76, 95% confidence interval = 0.63-0.92 for TGC versus CAT).
18611262
2008
rs754204
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Malignant neoplasm of breast
0.010
GeneticVariation
BEFREE
Three of the 11 SNPs for IRS2 were associated with breast cancer (rs4773082, P = 0.007; rs2289046, P = 0.016; rs754204 , P = 0.03).
18611262
2008
rs754204
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Breast Carcinoma
0.010
GeneticVariation
BEFREE
Three of the 11 SNPs for IRS2 were associated with breast cancer (rs4773082, P = 0.007; rs2289046, P = 0.016; rs754204 , P = 0.03).
18611262
2008
rs1805097
×
Entrez Id:
8660
Gene Symbol:
IRS2
IRS2
Malignant tumor of colon
0.010
GeneticVariation
BEFREE
We evaluated the effect of polymorphisms in four insulin-related genes (G972R in IRS1, G1057D in IRS2, a CA repeat in IGFI and an A/C polymorphism at -202 of IGFBP3) on the risk of microsatellite instability and KRAS2 and TP53 mutations in a population-based set of 1788 cases of colon cancer and 1981 controls.
16448675
2006